{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 504"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Federal Food, Drug, and Cosmetic Act to\n\t\t  ensure that valid generic drugs may enter the market."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130307", "#text": "March 7, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "SSHR00", "#text": "Committee on Health,\n\t\t\t Education, Labor, and Pensions"}, "sponsor": {"#tail": " (for\n\t\t\t himself, ", "#text": "Mr. Franken", "@name-id": "S332"}, "cosponsor": [{"#tail": ",\n\t\t\t ", "#text": "Mr. Vitter", "@name-id": "S299"}, {"#tail": ", ", "#text": "Mr. Durbin", "@name-id": "S253"}, {"#tail": ", and ", "#text": "Mrs. Shaheen", "@name-id": "S324"}, {"#tail": ") introduced the following bill; which was read twice and\n\t\t\t referred to the ", "#text": "Mr.\n\t\t\t Sanders", "@name-id": "S313"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@public-private": "public", "legis-body": {"#tail": "\n", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": [{"short-title": {"#tail": "\n        ", "#text": "Fair And Immediate Release of\n\t\t\t Generic Drugs Act "}, "#tail": " or the ", "#text": "\n          "}, {"short-title": {"#tail": "\n        ", "#text": "FAIR Generics Act"}, "#tail": ".", "#text": "\n          "}], "#text": "This Act may be cited as\n\t\t\t the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short\n\t\t\t title"}, "#text": "\n      ", "@id": "S1"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "180-Day\n\t\t\t exclusivity period amendments regarding first applicant status"}, "subsection": [{"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Amendments to\n\t\t\t Federal Food, Drug, and Cosmetic Act"}, "paragraph": [{"#tail": "\n        ", "@id": "IDbc6d731c151c43a88c1217124c6e7504", "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "In\n\t\t\t general"}, "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 505(j)(5)(B) of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(j)(5)(B)", "@value": "usc/21/355/j/5/B"}, "@parsable-cite": "usc/21/355", "#text": "\n                ", "@legal-doc": "usc"}}}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "clause\n\t\t\t (iv)(II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:iv/scl:II"}, "#text": "in "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "item (bb)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:iv/scl:II/i:bb"}, "#text": "by\n\t\t\t striking "}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "id75184DCBDD8141FD9731CB9FA27B929E", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as ", "@entity-type": "act", "#text": "items (cc) and (dd)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:iv/scl:II/i:cc, dd"}, {"#tail": ", respectively;\n\t\t\t and", "@entity-type": "act", "#text": "items (bb) and (cc)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:iv/scl:II/i:bb, cc", "@proposed": "true"}], "#text": "by\n\t\t\t redesignating "}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "idDF4638148C314F7DAFB5222A16DF8E6B", "#text": "\n              "}], "#text": "\n            ", "@id": "id7189819659D84B4E825654171F2A4802"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "by adding at the\n\t\t\t end the following:"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n            ", "#text": "."}, "#tail": "\n\t\t\t\t\t", "clause": [{"@indent": "up3", "#tail": "\n              ", "subclause": [{"#tail": "\n                ", "item": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " is submitted for approval of a drug,\n\t\t\t\tsubmits a substantially complete application that contains and lawfully\n\t\t\t\tmaintains a certification described in ", "@entity-type": "act", "#text": "paragraph (2)(A)(vii)(IV)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A/cl:vii/scl:IV"}, {"#tail": " for the drug;\n\t\t\t\tand", "@entity-type": "act", "#text": "paragraph (2)(A)(vii)(IV)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A/cl:vii/scl:IV"}], "#text": "that, on the first day\n\t\t\t\ton which a substantially complete application containing a certification\n\t\t\t\tdescribed in "}, "enum": {"#tail": "\n                    ", "#text": "(aa)"}, "@display-inline": "yes-display-inline", "#text": "\n                    ", "@id": "id511902278CDE4F2FA469536435C660E5", "@commented": "no"}, {"@indent": "up1", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; or", "@entity-type": "act", "#text": "clause (vii)(II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:vii/scl:II", "@proposed": "true"}, "#text": "that has not entered into a\n\t\t\t\tdisqualifying agreement described under "}, "enum": {"#tail": "\n                    ", "#text": "(bb)"}, "#text": "\n                    ", "@id": "idC1F279C52DA7419596F2E10BF86F5DC3"}], "enum": {"#tail": "\n                  ", "#text": "(I)"}, "@id": "idAC05111366AF4C3CB46A2FBAF22FE08C", "#text": "\n                  "}, {"#tail": "\n              ", "item": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and that, with respect to the applicant and\n\t\t\t\tdrug, each requirement described in ", "@entity-type": "act", "#text": "subclause (I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:v/scl:I", "@proposed": "true"}, {"#tail": " is satisfied; and", "@entity-type": "act", "#text": "clause (vi)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:vi", "@proposed": "true"}], "#text": "for the drug that is\n\t\t\t\tnot described in "}, "enum": {"#tail": "\n                    ", "#text": "(aa)"}, "@display-inline": "yes-display-inline", "#text": "\n                    ", "@id": "idF657711E907E4FEBB26A2B3E89DBE9E3", "@commented": "no"}, {"@indent": "up1", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "clause (vii)(II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:vii/scl:II", "@proposed": "true"}, "#text": "that has not entered into a\n\t\t\t\tdisqualifying agreement described under "}, "enum": {"#tail": "\n                    ", "#text": "(bb)"}, "#text": "\n                    ", "@id": "id6A17EC58D89A4680B169EB6655A202C1"}], "enum": {"#tail": "\n                  ", "#text": "(II)"}, "@id": "id61033FA684994005B76A355D49F9DFEE", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(v)"}, "header": {"#tail": "\n                ", "#text": "First applicant\n\t\t\t\tdefined"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means an applicant\u2014", "#text": "first\n\t\t\t\tapplicant"}, "#text": "As used in this subsection, the term "}, "#text": "\n                ", "@id": "idFC020D43F9E24E30B1644B9D46E7DF1D"}, {"@indent": "up3", "#tail": "\n              ", "subclause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " submitted and lawfully maintains a certification described in ", "@entity-type": "act", "#text": "clause\n\t\t\t\t(v)(II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:v/scl:II", "@proposed": "true"}, {"#tail": " or a statement described in ", "@entity-type": "act", "#text": "paragraph\n\t\t\t\t(2)(A)(vii)(IV)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A/cl:vii/scl:IV"}, {"#tail": " for each\n\t\t\t\tunexpired patent for which a first applicant described in ", "@entity-type": "act", "#text": "paragraph (2)(A)(viii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A/cl:viii"}, {"#tail": " had\n\t\t\t\tsubmitted a certification described in ", "@entity-type": "act", "#text": "clause (v)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:v/scl:I", "@proposed": "true"}, {"#tail": " on the first\n\t\t\t\tday on which a substantially complete application con\u00adtain\u00ading such a\n\t\t\t\tcertification was submitted.", "@entity-type": "act", "#text": "paragraph (2)(A)(vii)(IV)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A/cl:vii/scl:IV"}], "#text": "The applicant described in "}, "enum": {"#tail": "\n                  ", "#text": "(I)"}, "@id": "id17C91423D5C7410B83FD8451EFCBCEB3", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " submitted a\n\t\t\t\tcertification described in ", "@entity-type": "act", "#text": "clause (v)(II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:v/scl:II", "@proposed": "true"}, {"#tail": ", no action for patent\n\t\t\t\tinfringement was brought against such applicant within the 45-day period\n\t\t\t\tspecified in ", "@entity-type": "act", "#text": "paragraph (2)(A)(vii)(IV)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:2/sp:A/cl:vii/scl:IV", "@proposed": "true"}, {"#tail": "; or if an action was brought within such\n\t\t\t\ttime period, such an action was withdrawn or dismissed by a court (including a\n\t\t\t\tdistrict court) without a decision that the patent was valid and infringed; or\n\t\t\t\tif an action was brought within such time period and was not withdrawn or so\n\t\t\t\tdismissed, such applicant has obtained the decision of a court (including a\n\t\t\t\tdistrict court) that the patent is invalid or not infringed (including any\n\t\t\t\tsubstantive determination that there is no cause of action for patent\n\t\t\t\tinfringement or invalidity, and including a settlement order or consent decree\n\t\t\t\tsigned and entered by the court stating that the patent is invalid or not\n\t\t\t\tinfringed).", "@entity-type": "act", "#text": "paragraph (5)(B)(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:iii"}], "#text": "With regard to each such unexpired\n\t\t\t\tpatent for which the applicant described in "}, "enum": {"#tail": "\n                  ", "#text": "(II)"}, "@id": "id88EAA3A7E5CF4AD3B24BB5F47EE28C30", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " has begun commercial marketing of such drug, the applicant described in\n\t\t\t\t", "@entity-type": "act", "#text": "clause\n\t\t\t\t(v)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:v/scl:I", "@proposed": "true"}, {"#tail": " does not begin commercial marketing of such drug until the date\n\t\t\t\tthat is 30 days after the date on which the applicant described in ", "@entity-type": "act", "#text": "clause (v)(II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:v/scl:II", "@proposed": "true"}, {"#tail": " began such commercial\n\t\t\t\tmarketing.", "@entity-type": "act", "#text": "clause\n\t\t\t\t(v)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:v/scl:I", "@proposed": "true"}], "#text": "If an applicant described in "}, "enum": {"#tail": "\n                  ", "#text": "(III)"}, "@id": "id6C8EDF3813A54DFBBC0E0A6512B87EB9", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(vi)"}, "header": {"#tail": "\n                ", "#text": "Requirement"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\trequirements described in this clause are the following:"}, "#text": "\n                ", "@id": "id9C7D942107E74E23939E3F2AB9E76CBD"}], "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t\t", "@id": "id062F1252272E409EABD43240FEBE52DC"}, "#text": "\n            ", "@id": "idE1ADF87F66434238B999027300C82A34"}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": "\n\t\t\t and inserting ", "#text": "The first applicant"}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ",", "@entity-type": "act", "#text": "subparagraph\n\t\t\t (B)(v)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:v/scl:I"}, "#text": "The first applicant, as defined in "}], "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by striking ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 505(j)(5)(D)(i)(IV) of such Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:D/cl:i/scl:IV"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C.\n\t\t\t 355(j)(5)(D)(i)(IV)", "@value": "usc/21/355/j/5/D/i/IV"}], "@entity-type": "law-citation", "#text": "\n              "}}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Conforming\n\t\t\t amendment"}, "#text": "\n          ", "@id": "IDc4a27ff356014a90822eaefdf619e67c"}], "#text": "\n        ", "@id": "ID6330cbed4e2a4d69910df9758f1950aa"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall apply only with respect to an\n\t\t\t application filed under ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Fair And Immediate Release of Generic Drugs Act/s:2/ss:a", "@proposed": "true"}, "#text": "The\n\t\t\t amendments made by ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " to which the amendments made by ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 505(j) of the Federal Food, Drug, and Cosmetic\n\t\t\t Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(j)", "@value": "usc/21/355/j"}, "@parsable-cite": "usc/21/355", "#text": "\n              ", "@legal-doc": "usc"}}, {"#tail": " apply.", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 1102(a) of the\n\t\t\t Medicare Prescription Drug, Improvement, and Modernization Act of 2003", "@value": "Medicare Prescription Drug, Improvement, and Modernization Act of 2003/s:1102/ss:a"}, {"#tail": ")", "@entity-type": "public-law", "#text": "Public\n\t\t\t Law 108\u2013173", "@value": "public-law/108/173"}], "@entity-type": "law-citation", "#text": "\n            "}]}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Applicability"}, "#text": "\n        ", "@id": "ID7877ead9b43446278c9a46d5cbb98204"}], "#text": "\n      ", "@id": "ID11c8c50a21c74d90849d012e200ec243"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "180-Day\n\t\t\t exclusivity period amendments regarding agreements to defer commercial\n\t\t\t marketing"}, "subsection": [{"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Amendments to\n\t\t\t Federal Food, Drug, and Cosmetic Act"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", is further amended by adding at the end\n\t\t\t the following:", "@entity-type": "act", "#text": "section 2", "@value": "Fair And Immediate Release of Generic Drugs Act/s:2", "@proposed": "true"}, "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", as amended by ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 505(j)(5)(B) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C.\n\t\t\t 355(j)(5)(B)", "@value": "usc/21/355/j/5/B"}], "@entity-type": "law-citation", "#text": "\n              "}}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "Limitations on\n\t\t\t agreements to defer commercial marketing date"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "clause": [{"@indent": "up2", "#tail": "\n            ", "subclause": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subparagraph\n\t\t\t\t(F) of this paragraph", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F"}, {"#tail": ", or ", "@entity-type": "act", "#text": "section 505A", "@value": "Federal Food, Drug, and Cosmetic Act/s:505A"}, {"#tail": ", (bb) not to begin the\n\t\t\t\tcommercial marketing of its drug on the earliest possible date after receiving\n\t\t\t\tan approval of its application that is made effective under this subparagraph,\n\t\t\t\t", "@entity-type": "act", "#text": "section 527", "@value": "Federal Food, Drug, and Cosmetic Act/s:527"}, {"#tail": ", ", "@entity-type": "act", "#text": "subparagraph (F) of this paragraph", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F"}, {"#tail": ", or ", "@entity-type": "act", "#text": "section 505A", "@value": "Federal Food, Drug, and Cosmetic Act/s:505A"}, {"#tail": ", or (cc) to\n\t\t\t\tboth ", "@entity-type": "act", "#text": "section 527", "@value": "Federal Food, Drug, and Cosmetic Act/s:527"}, {"#tail": " and ", "@entity-type": "act", "#text": "items (aa)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:vii/scl:I/i:aa", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "(bb)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:vii/scl:I/i:bb", "@proposed": "true"}], "#text": "An agreement described in this\n\t\t\t\tsubclause is an agreement between a first applicant and the holder of the\n\t\t\t\tapplication for the listed drug or an owner of one or more of the patents as to\n\t\t\t\twhich any applicant submitted a certification qualifying such applicant for the\n\t\t\t\t180-day exclusivity period whereby that applicant agrees, directly or\n\t\t\t\tindirectly, (aa) not to seek an approval of its application that is made\n\t\t\t\teffective on the earliest possible date under this subparagraph, "}, "enum": {"#tail": "\n                ", "#text": "(I)"}, "header": {"#tail": "\n                ", "#text": "Agreement to defer approval or\n\t\t\t\tcommercial marketing date"}, "#text": "\n                ", "@id": "id3BCBB59EA21A43BC92585341D54E464F"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "An agreement described in\n\t\t\t\tthis subclause is an agreement between an applicant and the holder of the\n\t\t\t\tapplication for the listed drug or an owner of one or more of the patents as to\n\t\t\t\twhich any applicant submitted a certification qualifying such applicant for the\n\t\t\t\t180-day exclusivity period whereby that applicant agrees, directly or\n\t\t\t\tindirectly, not to seek an approval of its application or not to begin the\n\t\t\t\tcommercial marketing of its drug until a date that is after the expiration of\n\t\t\t\tthe 180-day exclusivity period awarded to another applicant with respect to\n\t\t\t\tsuch drug (without regard to whether such 180-day exclusivity period is awarded\n\t\t\t\tbefore or after the date of the agreement)."}, "enum": {"#tail": "\n                ", "#text": "(II)"}, "header": {"#tail": "\n                ", "#text": "Agreement that disqualifies\n\t\t\t\tapplicant from first applicant status"}, "#text": "\n                ", "@id": "id2100E98E2D8C4787B83D9027C112363A"}], "enum": {"#tail": "\n              ", "#text": "(vii)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Agreement by first applicant to\n\t\t\t\tdefer commercial marketing; limitation on acceleration of deferred commercial\n\t\t\t\tmarketing date"}, "#text": "\n              ", "@id": "ID8a16b9ede9a54dfbaaef407fdd8bcb07"}, {"@indent": "up2", "#tail": "\n            ", "subclause": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the applicant may seek an approval\n\t\t\t\tof its application or begin such commercial marketing on the date that is the\n\t\t\t\tearlier of\u2014"}, "enum": {"#tail": "\n                ", "#text": "(I)"}, "item": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subparagraph (F) of this paragraph", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F"}, {"#tail": ", or ", "@entity-type": "act", "#text": "section\n\t\t\t\t505A", "@value": "Federal Food, Drug, and Cosmetic Act/s:505A"}, {"#tail": ", or begin the commercial marketing of such drug, without\n\t\t\t\tregard to any other provision of such agreement pursuant to which the\n\t\t\t\tcommercial marketing could begin on an earlier date; or", "@entity-type": "act", "#text": "section 527", "@value": "Federal Food, Drug, and Cosmetic Act/s:527"}], "#text": "the latest date set forth in the\n\t\t\t\tagreement on which that applicant can receive an approval that is made\n\t\t\t\teffective under this subparagraph, "}, "enum": {"#tail": "\n                  ", "#text": "(aa)"}, "@id": "id00286B1642FE4134BCF26D96F4ACD759", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "180 days after another first applicant\n\t\t\t\tbegins commercial marketing of such drug; and"}, "enum": {"#tail": "\n                  ", "#text": "(bb)"}, "@id": "id95ACCEA6874C4196BA5DFFD3F4BEB518", "#text": "\n                  "}], "#text": "\n                ", "@id": "id796AC24DE5064AE89C4452D890D9F9D0"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subparagraph (F) of this paragraph", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:F"}, {"#tail": ", or ", "@entity-type": "act", "#text": "section\n\t\t\t\t505A", "@value": "Federal Food, Drug, and Cosmetic Act/s:505A"}, {"#tail": ", or begin the commercial marketing of such drug, without\n\t\t\t\tregard to any other provision of such agreement pursuant to which commercial\n\t\t\t\tmarketing could begin on an earlier date, shall be the date used to determine\n\t\t\t\twhether an applicant is disqualified from first applicant status pursuant to\n\t\t\t\t", "@entity-type": "act", "#text": "section 527", "@value": "Federal Food, Drug, and Cosmetic Act/s:527"}, {"#tail": ".", "@entity-type": "act", "#text": "clause\n\t\t\t\t(vii)(II)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:vii/scl:II", "@proposed": "true"}], "#text": "the latest date set forth in the\n\t\t\t\tagreement on which that applicant can receive an approval that is made\n\t\t\t\teffective under this subparagraph, "}, "enum": {"#tail": "\n                ", "#text": "(II)"}, "@id": "id90E43F67E8E14ECE88A62341D3367419", "#text": "\n                "}], "enum": {"#tail": "\n              ", "#text": "(viii)"}, "header": {"#tail": "\n              ", "#text": "Limitation on\n\t\t\t\tacceleration"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t\tincludes more than 1 possible date when an applicant may seek an approval of\n\t\t\t\tits application or begin the commercial marketing of its drug\u2014", "@entity-type": "act", "#text": "clause (vii)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:vii/scl:I", "@proposed": "true"}, "#text": "If an agreement described in "}, "#text": "\n              ", "@id": "idF68A0ED0F925446088097254CDE8F268"}], "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "id4C3D872B8665425B8C7A3E91481B5062"}, "#text": "\n          ", "@id": "ID2b6f4468ee824d7d8d1f500bb607b062"}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by\n\t\t\t adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 505(j) of such Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(j)", "@value": "usc/21/355/j"}, "@parsable-cite": "usc/21/355", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Notification of\n\t\t\t FDA"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "paragraph": {"@indent": "up1", "#tail": "\n            ", "@id": "id258EF44DD8EC4556BAFD25E519E7C365", "enum": {"#tail": "\n              ", "#text": "(11)"}, "#text": "\n              ", "subparagraph": [{"@display-inline": "yes-display-inline", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " a\n\t\t\t\tnotification that includes\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The holder of an\n\t\t\t\tabbreviated application under this subsection shall submit to the "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "clause": [{"@indent": "up1", "#tail": "\n                ", "@id": "id97B739EBA40E4368A07CA39B43D263FB", "enum": {"#tail": "\n                  ", "#text": "(i)"}, "#text": "\n                  ", "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";\n\t\t\t\tor", "@entity-type": "act", "#text": "paragraph (5)(B)(vii)(I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:vii/scl:I"}, "#text": "the text of any\n\t\t\t\tagreement entered into by such holder described under "}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                    ", "@id": "id6BC12AC1CD5540A098FA669F8DCF6A2E", "@commented": "no"}, {"@indent": "up1", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "if such an agreement has not been\n\t\t\t\treduced to text, a written detailed description of such agreement that is\n\t\t\t\tsufficient to disclose all the terms and conditions of the agreement;\n\t\t\t\tand"}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "#text": "\n                    ", "@id": "id48EF35BC525A40DCA8E088C294D5A294"}]}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "clause (i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:11/sp:A/cl:i", "@proposed": "true"}, "#text": "the text, or a written detailed\n\t\t\t\tdescription in the event of an agreement that has not been reduced to text, of\n\t\t\t\tany other agreements that are contingent upon, provide a contingent condition\n\t\t\t\tfor, or are otherwise related to an agreement described in "}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "#text": "\n                  ", "@id": "id7810422424D24170B4BFEC0DF5F84D0E"}], "#text": "\n                ", "@id": "id8BA2581345A9494FAD6142F15879D519", "@commented": "no"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be submitted not later than 10 business days after\n\t\t\t\texecution of the agreement described in ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:11/sp:A", "@proposed": "true"}, {"#tail": ". Such notification\n\t\t\t\tis in addition to any notification required under ", "@entity-type": "act", "#text": "subparagraph (A)(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:11/sp:A/cl:i", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "section 1112 of the Medicare\n\t\t\t\tPrescription Drug, Improvement, and Modernization Act of 2003", "@value": "Medicare Prescription Drug, Improvement, and Modernization Act of 2003/s:1112"}], "#text": "The notification described under\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "#text": "\n                ", "@id": "id5C9D77465B32412C8F0B9F5F7479BE38"}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " pursuant to this paragraph shall be exempt\n\t\t\t\tfrom disclosure under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", and no such\n\t\t\t\tinformation or documentary material may be made public, except as may be\n\t\t\t\trelevant to any administrative or judicial action or proceeding. Nothing in\n\t\t\t\tthis paragraph is intended to prevent disclosure to either body of the ", "@entity-type": "uscode", "#text": "\n                    ", "external-xref": {"#tail": " of title 5, United States Code", "@parsable-cite": "usc/5/552", "#text": "section 552", "@legal-doc": "usc"}, "@value": "usc/5/552"}, {"#tail": "\n\t\t\t\tor to any duly authorized committee or subcommittee of the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}], "#text": "Any information or documentary\n\t\t\t\tmaterial filed with the "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "#text": "\n                ", "@id": "id05D23BC53A8D4FCE91C31B1B8BA03DC9"}]}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "id92543B96C89246AA96E0FA28D7610EC9"}, "#text": "\n          ", "@id": "ID274147e1bc1e4e829fb9ba5cbba0abfc"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and inserting ", "#text": "505 (i) or (k)"}, {"#tail": ".", "#text": "505 (i), (j)(11),\n\t\t\t or (k)"}], "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by\n\t\t\t striking ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 301(e) of such Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:301/ss:e"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 331(e)", "@value": "usc/21/331/e"}, "@parsable-cite": "usc/21/331", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "header": {"#tail": "\n          ", "#text": "Prohibited\n\t\t\t acts"}, "#text": "\n          ", "@id": "IDd27f5d987fc5464eab7db22282cbb94c"}], "#text": "\n        ", "@id": "IDa57973e12bf7408bb4e4ca2272a32c2f"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", is amended by adding at the end the\n\t\t\t following:", "@entity-type": "uscode", "#text": "Section 271(e) of\n\t\t\t title 35, United States Code", "@value": "usc/35/271/e"}, "#text": "\n          ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Infringement of\n\t\t\t patent"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "paragraph": {"@indent": "up1", "#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " has published information pursuant to ", "@entity-type": "federal-body", "#text": "Secretary of Health and\n\t\t\t\tHuman Services", "@entity-id": "7500"}, {"#tail": " or\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (b)(1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b/p:1"}, {"#tail": " shall be an\n\t\t\t\taction brought under this subsection within the 45-day period described in\n\t\t\t\t", "@entity-type": "act", "#text": "(c)(2) of section 505 of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:2"}, {"#tail": " or ", "@entity-type": "act", "#text": "subsection (j)(5)(B)(iii)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:iii"}, {"#tail": ".", "@entity-type": "act", "#text": "(c)(3)(C) of section 505 of the Federal Food,\n\t\t\t\tDrug, and Cosmetic\n\t\t\t\tAct", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:c/p:3/sp:C"}], "#text": "The exclusive remedy under this\n\t\t\t\tsection for an infringement of a patent for which the "}, "enum": {"#tail": "\n            ", "#text": "(7)"}, "#text": "\n            ", "@id": "id083C8BD9829A4876B838C909B072A884", "@commented": "no"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id1A4A441502CA4B5CB0C8588CFF4F54D9"}, "#text": "\n        ", "@id": "id16BEAD7F09334ACA9C246D678D72CBA6"}, {"#tail": "\n    ", "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Applicability"}, "paragraph": [{"#tail": "\n        ", "@id": "id969843E1653B4421917CDBDDEA094CA1", "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "Limitations on\n\t\t\t acceleration of deferred commercial marketing date"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall apply only with respect to\u2014", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Fair And Immediate Release of Generic Drugs Act/s:3/ss:a/p:1", "@proposed": "true"}, "#text": "The amendment\n\t\t\t made by "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "an application\n\t\t\t filed under ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " to which the amendments made by ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 505(j) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21\n\t\t\t U.S.C. 355(j)", "@value": "usc/21/355/j"}], "@entity-type": "law-citation", "#text": "\n                "}, {"#tail": " apply; and", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 1102(a) of the Medicare\n\t\t\t Prescription Drug, Improvement, and Modernization Act of 2003", "@value": "Medicare Prescription Drug, Improvement, and Modernization Act of 2003/s:1102/ss:a"}, {"#tail": ")", "@entity-type": "public-law", "#text": "Public Law\n\t\t\t 108\u2013173", "@value": "public-law/108/173"}], "@entity-type": "law-citation", "#text": "\n                "}]}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "id8950AB1A3BF64B558BE86764F142AD6F", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (as added by ", "@entity-type": "act", "#text": "section 505(j)(5)(B)(vii)(I) of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:vii/scl:I", "@proposed": "true"}, {"#tail": ") executed after the date of\n\t\t\t enactment of this Act.", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Fair And Immediate Release of Generic Drugs Act/s:2/ss:a/p:1", "@proposed": "true"}], "#text": "an agreement\n\t\t\t described under "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "IDb86db9e1370c4c24908624d69993b4b8", "#text": "\n            "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and ", "@entity-type": "act", "#text": "paragraphs (2)", "@value": "Fair And Immediate Release of Generic Drugs Act/s:2/ss:a/p:2", "@proposed": "true"}, {"#tail": " shall apply only with respect to an agreement described under ", "@entity-type": "act", "#text": "(3) of subsection\n\t\t\t (a)", "@value": "Fair And Immediate Release of Generic Drugs Act/s:2/ss:a/p:3", "@proposed": "true"}, {"#tail": " (as added by\n\t\t\t ", "@entity-type": "act", "#text": "section\n\t\t\t 505(j)(5)(B)(vii)(I) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j/p:5/sp:B/cl:vii/scl:I", "@proposed": "true"}, {"#tail": ") executed after the date of enactment of this Act.", "@entity-type": "act", "#text": "subsection (a)(1)", "@value": "Fair And Immediate Release of Generic Drugs Act/s:2/ss:a/p:1", "@proposed": "true"}], "#text": "The amendments made by "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Notification of\n\t\t\t FDA"}, "#text": "\n          ", "@id": "ID1712456ef18c4b7c8e9569acd5b2fa47"}], "#text": "\n        ", "@id": "ID0ea03683aa68491d9b0e96bcf486d8b1"}], "#text": "\n      ", "@id": "IDaa05ca3397834cd18cc37eaa41730c75"}], "#text": "\n\t\t"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-03-07"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S504 IS: Fair And Immediate Release of Generic Drugs Act "}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}